Drug Companies' Liability for the Opioid Epidemic

Affiliations

¹ From the Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor (R.L.H); and Stanford Law School and the Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (M.M.M.).

Rebecca L Haffajee et al. N Engl J Med. 2017.

. 2017 Dec 14;377(24):2301-2305.

doi: 10.1056/NEJMp1710756.

¹ From the Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor (R.L.H); and Stanford Law School and the Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA (M.M.M.).

No abstract available

References

1. Press Release: New data show continuing opioid epidemic in the United States. Centers for Disease Control and Prevention (CDC) Newsroom, December 16, 2016. (Accessed August 5, 2017 at https://www.cdc.gov/media/releases/2016/p1216-continuing-opioid-epidemic....
1. Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington, D.C.: The National Academies of Sciences Engineering Medicine, 2017. (Accessed August 5, 2017 at http://nationalacademies.org/hmd/reports/2017/pain-management-and-the-op....) - PubMed
1. Ausness RC. The role of litigation in the fight against prescription drug abuse. West VA Law Rev 2014;116:1117–1165.
1. Van Zee A The promotion and marketing of OxyContin: commercial triumph, public health tragedy. Am J Public Health 2009;99(2):221–227. - PMC - PubMed
1. U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member’s Office: Minority Staff Report. Fueling an Epidemic: Insys Therapeutics and the Systematic Manipulation of Prior Authorization; 2017. (Accessed September 11, 2017 at https://www.hsgac.senate.gov/media/minority-media/mccaskill-announces-co....)